HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kavet, J Search for Related Content PubMed PubMed Citation Articles by Kavet, J

A perspective on the significance of pandemic influenza.

J Kavet

The identification in February 1976 of a new strain of influenza virus led to the enactment of unprecedented federal legislation to minimize the impact of a potential outbreak of pandemic influenza in the fall and winter of 1976-1977. This legislative program does not, however, represent a commitment of federal resources to deal with the more general, longstanding problem of epidemic influenza. This paper presents a series of estimates of the impact and economic consequences of influenza. By including periods of interpandemic as well as pandemic disease, the estimates offer a broadened perspective of the magnitude of the influenza problem. The estimates show that while the proportions of pandemic influenza can be singularly impressive, the cumulative effects of interpandemic outbreaks are generally of greater consequence. The paper discusses the implications of these estimates and the 1976 legislation for the support and implementation of federal policy on the use of influenza vaccine. While the commitment of resources in support of public policy cannot alone guarantee successful implementation, it must be considered an essential prerequisite for dealing with both interpandemic and pandemic influenza.

This article has been cited by other articles:

				W. Schaffner, S. J. Rehm, and T. A. Elasy Influenza Vaccination: An Unmet Need in Patients With Diabetes Clin. Diabetes, October 1, 2007; 25(4): 145 - 149. [Abstract] [Full Text] [PDF]

				A. P. Galvani, T. C. Reluga, and G. B. Chapman Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum PNAS, March 27, 2007; 104(13): 5692 - 5697. [Abstract] [Full Text] [PDF]

				K. L. Nichol Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza Arch Intern Med, March 12, 2001; 161(5): 749 - 759. [Abstract] [Full Text] [PDF]

				J. C. Lin and K. L. Nichol Excess Mortality Due to Pneumonia or Influenza During Influenza Seasons Among Persons With Acquired Immunodeficiency Syndrome Arch Intern Med, February 12, 2001; 161(3): 441 - 446. [Abstract] [Full Text] [PDF]

				K. L. Nichol, G. B. Byrnes, H. Kelly, P. Muennig, S. Y. Chu, J. A. Singleton, M. M. McCauley, W. A. Orenstein, J. M. Hughes, A. C. Mawle, et al. Influenza Vaccine for Healthy Working Adults JAMA, January 17, 2001; 285(3): 290 - 292. [Full Text] [PDF]

				J. J. Treanor, F. G. Hayden, P. S. Vrooman, R. Barbarash, R. Bettis, D. Riff, S. Singh, N. Kinnersley, P. Ward, R. G. Mills, et al. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza: A Randomized Controlled Trial JAMA, February 23, 2000; 283(8): 1016 - 1024. [Abstract] [Full Text] [PDF]